arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

HCA Healthcare, Inc.

HCA Health Care Hospital/Nursing Management
$405.00
▼ -0.0% Today
as of Sep 4, 16:49 ET
Last 30 days -3.15% Jul 28 → Sep 04
$393.11 $402.81 $412.51 $422.22 $431.92 Jul 28 Aug 05 Aug 12 Aug 20 Aug 27 Sep 04
Open
$404.30
High
$419.57
Low
$401.00
Volume
$929,122
Avg Vol
$1M
Mkt Cap
$88.5B
P/E (TTM)
19.34
Beta
—
52w High
$556.52
52w Low
$353.99
Div Yield
—
Shares Out
$223M

Recent Press Releases & News last 60 days · 25 items

mixed ▲ 1 ● 23 ▼ 1
Sep 4 · 20:11 Simply Wall St. neutral
HCA Healthcare (HCA) Could Be 11% Below Fair Value As Guidance Gets Cut
Sep 3 · 15:52 Barchart neutral
Is HCA Healthcare Stock Underperforming the Nasdaq?
Sep 2 · 16:16 LAYOFFS MT Newswires bearish
HCA Healthcare's Reported Layoffs Consistent With Management's Resiliency Initiatives, RBC Says
▸ Show all 25 press releases & news Free account →

Overview

52-week range
$354
$557
25% of range
Avg surprise (last 2)
+11.1%
Avg reaction (last 2)
-3.0%
0% positive
Latest IV / EM
29%
EM ±4.5% · $405 · Sep 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$3.91$4.72$5.53$6.34$7.15 Actual $3.91Actual $4.85Actual $4.29Actual $3.91Actual $5.93Actual $5.53Actual $4.88Actual $6.45Est $5.77Actual $6.84Est $6.19Actual $6.96Actual $7.15 SepMarJunSepMarJunSepMar/2025Jun/2025SepMar
Revenue vs Net Income Revenue Net income
$0$5.0B$10.1B$15.1B$20.1B Jun 24Sep 24Mar 25Jun 25Sep 25Mar 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue Mar 31, 2026Mar 2026 $7.15 — — — — financials
Tue Sep 30, 2025Sep 2025 $6.96 — — — — financials
Fri Jul 25, 2025Jun/2025 $6.84 $6.19 +10.5% — -2.1% earnings
Fri Apr 25, 2025Mar/2025 $6.45 $5.77 +11.8% — -4.0% earnings
Mon Sep 30, 2024Sep 2024 $4.88 — — — — financials
Sun Jun 30, 2024Jun 2024 $5.53 — — — — financials
Sun Mar 31, 2024Mar 2024 $5.93 — — — — financials
Sat Sep 30, 2023Sep 2023 $3.91 — — — — financials
Fri Jun 30, 2023Jun 2023 $4.29 — — — — financials
Fri Mar 31, 2023Mar 2023 $4.85 — — — — financials
Fri Sep 30, 2022Sep 2022 $3.91 — — — — financials

Financials

Income statement (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Revenue$19.11B—$19.16B$18.61B$18.32B—$17.49B$17.49B
Cost of revenue————————
Gross profit————————
Operating income————————
Net income$1.62B—$1.64B$1.65B$1.61B—$1.27B$1.46B
EPS (diluted)$7.15—$6.96$6.83$6.45—$4.88$5.53

Balance sheet (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Cash & equivalents$940M$1.04B$997M$939M$1.06B$1.93B$2.89B$831M
Inventory$1.68B$1.65B$1.73B$1.79B$1.79B$1.74B$1.78B$1.80B
Total current assets$16.05B$15.78B$15.29B$15.56B$16.26B$16.41B$16.66B$15.17B
Total assets$61.45B$60.72B$59.75B$59.54B$59.80B$59.51B$59.46B$57.38B
Long-term debt$39.49B$41.60B$38.40B$39.38B$41.06B$38.33B$38.28B$36.31B
Total liabilities————————
Total equity$-6.30B$-6.03B$-2.16B$-1.24B$-438M$-2.50B$786M$1.34B

Implied volatility — last 90 days

26%37%48%60%71% Jun 07 — IV 35% · EM ±4.9%Jun 08 — IV 34% · EM ±4.5%Jun 09 — IV 35% · EM ±4.3%Jun 10 — IV 35% · EM ±4.1%Jun 11 — IV 36% · EM ±4.0%Jun 12 — IV 30% · EM ±3.1%Jun 15 — IV 36% · EM ±2.6%Jun 16 — IV 37% · EM ±2.2%Jun 17 — IV 45% · EM ±1.9%Jun 19 — IV 31% · EM ±6.7%Jun 22 — IV 32% · EM ±6.7%Jun 23 — IV 31% · EM ±6.3%Jun 24 — IV 33% · EM ±6.7%Jun 25 — IV 33% · EM ±6.4%Jun 26 — IV 33% · EM ±6.3%Jun 29 — IV 33% · EM ±5.9%Jun 30 — IV 32% · EM ±5.5%Jul 01 — IV 31% · EM ±5.2%Jul 02 — IV 32% · EM ±5.2%Jul 03 — IV 34% · EM ±5.2%Jul 06 — IV 34% · EM ±4.7%Jul 07 — IV 38% · EM ±5.1%Jul 08 — IV 39% · EM ±4.9%Jul 09 — IV 39% · EM ±4.6%Jul 10 — IV 53% · EM ±5.8%Jul 13 — IV 72% · EM ±6.0%Jul 14 — IV 48% · EM ±3.5%Jul 15 — IV 47% · EM ±2.8%Jul 16 — IV 62% · EM ±2.6%Jul 20 — IV 42% · EM ±9.9%Jul 21 — IV 41% · EM ±9.6%Jul 22 — IV 42% · EM ±9.6%Jul 23 — IV 43% · EM ±9.7%Jul 24 — IV 35% · EM ±7.7%Jul 27 — IV 36% · EM ±7.6%Jul 28 — IV 36% · EM ±7.5%Jul 29 — IV 36% · EM ±7.1%Jul 30 — IV 36% · EM ±7.1%Jul 31 — IV 35% · EM ±6.7%Aug 03 — IV 36% · EM ±6.4%Aug 04 — IV 37% · EM ±6.3%Aug 05 — IV 35% · EM ±5.9%Aug 06 — IV 34% · EM ±5.5%Aug 07 — IV 32% · EM ±5.0%Aug 10 — IV 33% · EM ±4.6%Aug 11 — IV 31% · EM ±4.1%Aug 12 — IV 29% · EM ±3.6%Aug 13 — IV 31% · EM ±3.6%Aug 14 — IV 27% · EM ±3.0%Aug 17 — IV 30% · EM ±2.5%Aug 18 — IV 34% · EM ±2.5%Aug 19 — IV 38% · EM ±2.2%Aug 20 — IV 39% · EM ±1.6%Aug 24 — IV 29% · EM ±6.0%Aug 25 — IV 29% · EM ±5.9%Aug 26 — IV 29% · EM ±5.7%Aug 27 — IV 27% · EM ±5.4%Aug 28 — IV 26% · EM ±5.0%Aug 31 — IV 28% · EM ±5.0%Sep 01 — IV 29% · EM ±5.0%Sep 02 — IV 28% · EM ±4.6%Sep 03 — IV 27% · EM ±4.4%Sep 04 — IV 29% · EM ±4.5%

Sector peers

LLY
Eli Lilly and Company
$1.1T $1,148.00-0.1%
JNJ
Johnson & Johnson
$671.0B $275.71+0.2%
ABBV
AbbVie Inc.
$430.9B $256.50+0.1%
MRK
Merck & Company, Inc.
$317.1B $150.33+0.0%
PM
Philip Morris International Inc
$299.3B $182.53+0.0%
NVS
Novartis AG
$297.9B $155.11-3.0%
View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in